7月17日，诺诚健华盘中下跌5.04%，报13.85港元，成交额8414.04万港元。公司所在生物科技板块今日集体大幅走弱，同板块康方生物跌12.18%、三生制药跌11.84%、科伦博泰生物跌6.79%、信达生物跌5.79%、百济神州跌2.67%，行业个股普遍承压。
消息面上，公司于7月15日及7月16日连续披露Soficitinib治疗中重度特应性皮炎III期研究及非节段型白癜风II期研究均达到主要终点的积极结果，但短期利好兑现叠加板块系统性回调，股价出现回落。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.